Novo to sell Wegovy subscriptions on Hims, LifeMD, and others

Novo Nordisk (NVO) stock is in focus as the company launches a Wegovy subscription program via telehealth firms including ...

Hims & Hers Health (HIMS) Is Up 8.3% After Expanding Novo Nordisk GLP-1 Partnership And Launching New Weight-Loss Membership - Has The Bull Case Changed?

In late March 2026, Hims & Hers Health, Inc. announced a renewed collaboration with Novo Nordisk to offer a broad range of FDA-approved GLP-1 medications, including Wegovy injections and the only ...

Hims GLP 1 Deal With Novo Nordisk Reshapes Growth And Valuation Story

Hims & Hers Health (NYSE:HIMS) is expanding access to FDA-approved GLP-1 medications through a new collaboration with Novo ...

Hims & Hers (HIMS) Taps Into $200-Billion Weight Loss Market, Soars 6%

Hims & Hers bounced back by 6.22 percent on Monday to close at $20.33 apiece, as investors positioned their second-quarter ...

Honest Hims hair growth review: What men should know before buying

Need a solution for your thinning hair line? We took a deep dive into Hims hair growth program to see how it works and who it ...
USA Today

Thinking about Hims for weight loss? Here’s what to know first

Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...